Canon Inc. · TSE:7751
Canon — 2025 Corporate Strategy Conference
14 slides from Canon's conference presentation, Mar 7, 2025
Slide 1: Medical Group
Canon Inc. 2025 Corporate Strategy Conference Medical Group March 7, 2025 Toshio Takiguchi Executive Vice President Head of Medical Group This presentation contains forward-looking statements with respect to future results, performance and achievements that are subject to risk and uncertainties and
Slide 2: Results up to 2024 & Challenges (Sales Growth)
Results up to 2024 & Challenges (Sales Growth) システム事業の売上推移 Canon Medical Net Sales Results 500 billion yen or more • Since 2019, over a four year period, increased sales more than 100 billion yen 400 billion yen or more • CAGR（’20-’24）+7％ 300 billion yen or more Challenges 200 billion yen or more Ne
Slide 3: P&L
P&L Net sales (Billions of yen) Profitability 700.0 8.0% Net sales Op. profit 6.7% 7.0% 600.0 6.1% 6.0% 5.7% 6.0% 500.0 4.3% 5.0% 400.0 4.0% 300.0 3.0% 568.8 590.0 480.4 513.3 553.8 200.0 2.0% 100.0 1.0% 29.4 31.0 31.6 39.5 24.7 0.0 0.0% 2021 2022 2023 2024 2025 (excludes impairment loss) 2
Slide 4: Results & Challenges / Strategies & Measures
Results & Challenges / Strategies & Measures Results & Challenges 【2024 net sales】: 568.8 billion yen (+2.7%Y/Y) 【Op. profit】: 24.7 billion yen (-22.1% Y/Y) 【Challenges】 ① Increase profitability by promoting efficient business operations ② Ensure "resilience" against rapid changes in exchange rates
Slide 5: Structure of Medical Business Innovation Committee
Structure of Medical Business Innovation Committee ⚫ Integrate CMSC with Canon's organization, human resources, know-how and culture. Purpose ⚫ Realize high profitability and high growth by reforming the business structure and strengthening the corporate structure to make the medical business a pill
Slide 6: Integration of CMSC with Canon Inc.
Integration of CMSC with Canon Inc. Canon Inc. CMSC Medical business HQ CMSC ●Medical components ●Medical systems Canon Inc. Medical business HQ ●Medical systems ●Medical components 5
Slide 7: Transformation toward new R&D structure
Transformation toward new R&D structure Solve challenges in the medical business and create new value by transforming R&D structure Collaboration CMSC Structure of Medical Business R&D Core Technology Group R&D after integration with Canon Inc. Development HQ Integration Product Production tech. Pro
Slide 8: Reorganize & Strengthen Sales Network in U.S. Mkt.
Reorganize & Strengthen Sales Network in U.S. Mkt. • Canon Healthcare USA, INC. (CHCU) will operate as U.S. headquarters of medical business • CHCU will be a holding company, overseeing all medical related companies in the United States Upstream marketing Medical business U.S. holding co. ・Formulate
Slide 9: Canon PCCT Research System: Global Research and Goals
Canon PCCT Research System: Global Research and Goals ◼ Promoting early empirical research to realize "Global No. 1 Highest Image Quality and Low Exposure" ◼ Maximize awareness of and expectations for Canon’s PCCT technology in global markets and academic circles to prepare for commercial product la
Slide 10: Major new product and features contributing to 2025
Major new product and features contributing to 2025 Aquilion ONE INSIGHT evolution Vantage Galan 3T / Supreme Edition Alphenix / Evolve Edition Incorporated with Canon’s proprietary AI tech. Redesigned HW to make use of AI tech. ◼ "CLEAR Motion Cardiac" AI dynamics correction added Expand out from w
Slide 11: Global service business reform
Global service business reform Aiming to maximize profits by expanding sales and improving efficiency • Minimize service business resources by strengthening remote services and streamlining installation, inspection, and repair, using DX • Offer services that raise customer asset value (Launch of SLA
Slide 12: 2025 Outlook (Final year of 5-year plan)
2025 Outlook（Final year of 5-year plan) Stage#2 Net sales +3.7% Y/Y 2023 2024 2025 profitability 6.7% Stage#1 Approach to achieve targets Realize growth through strengthened 2020 2022 structure and prepared growth engines Achieve sales target (Strengthen product competitiveness Prepare growth engine
Slide 13: Direction of Medical Group – Contribute to precision medicine
Direction of Medical Group – Contribute to precision medicine Current business areas Business expansion areas Exam and diagnostic Solutions that support personalized treatment In vitro diagnostics & Bio In vitro testing Realize Clinical Various reagents Pathological diagnosis Decision Support Liquid
Slide 14: Made for patients. Made for you. Made for partnerships.
Made for patients. Made for you Made for partnerships.